Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ReNeuron gets notice of US cryptopreservation patent

ReNeuron is using cryopreservation technology in its CTX stem cell line
ReNeuron gets notice of US cryptopreservation patent
Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology

ReNeuron (LON:RENE) has received a  Notice of Allowance from the US Patent and Trademark Office for a key patent application covering its cell cryopreservation technology. 

The patent application contains broad claims relating to cryopreserved neural, retinal and mesenchymal stem cells using a formulation developed by ReNeuron that is free of toxic cryopreservants.  

ReNeuron is using cryopreservation technology in its CTX stem cell line to derive a cryopreserved, long shelf life cell therapy candidate, designated CTXcryo.

Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology.  

Olav Hellebø, ReNeuron’s chief executive added the company had invested heavily in patents in recent and the US Notice of Allowance for cell cryopreservation was another important addition.

PhilW.jpg
Why Invest In ReNeuron Group Plc? Read More Here

Register here to be notified of future RENE Company articles
View full RENE profile

ReNeuron Group Plc Timeline

Related Articles

Knee surgery
July 13 2016
The treatment involves removing cellular material from animal and human tissue to leave a matrix which gives a framework for population by the patient’s own cells.
Astrazeneca1_5704c41deea83.jpg
April 06 2016
Researchers administered Atu027 to patients with pancreatic cancer, one of the hardest strains of the disease to treat.
Dendritic cells with T-lymphocytes
Thu
With cases of skin cancer on the rise, Scancell's immunotherapy study data has come at the right time, but is it enough to offset the insecurity in the sector?

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.